Binding Sites for Abundant Nuclear Factors Modulate RNA Polymerase I-dependent Enhancer Function in Saccharomyces Cerevisiae
Overview
Authors
Affiliations
The 190-base pair (bp) rDNA enhancer within the intergenic spacer sequences of Saccharomyces cerevisiae rRNA cistrons activates synthesis of the 35S-rRNA precursor about 20-fold in vivo (Mestel,, R., Yip, M., Holland, J. P., Wang, E., Kang, J., and Holland, M. J. (1989) Mol. Cell. Biol. 9, 1243-1254). We now report identification and analysis of transcriptional activities mediated by three cis-acting sites within a 90-bp portion of the rDNA enhancer designated the modulator region. In vivo, these sequences mediated termination of transcription by RNA polymerase I and potentiated the activity of the rDNA enhancer element. Two trans-acting factors, REB1 and REB2, bind independently to sites within the modulator region (Morrow, B. E., Johnson, S. P., and Warner, J. R. (1989) J. Biol. Chem. 264, 9061-9068). We show that REB2 is identical to the ABF1 protien. Site-directed mutagenesis of REB1 and ABF1 binding sites demonstrated uncoupling of RNA polymerase I-dependent termination from transcriptional activation in vivo. We conclude that REB1 and ABF1 are required for RNA polymerase I-dependent termination and enhancer function, respectively, Since REB1 and ABF1 proteins also regulate expression of class II genes and other nuclear functions, our results suggest further similarities between RNA polymerase I and II regulatory mechanisms. Two rDNA enhancers flanking a rDNA minigene stimulated RNA polymerase I transcription in a "multiplicative" fashion. Deletion mapping analysis showed that similar cis-acting sequences were required for enhancer function when positioned upstream or downstream from a rDNA minigene.
Functional architecture of the Reb1-Ter complex of Schizosaccharomyces pombe.
Jaiswal R, Choudhury M, Zaman S, Singh S, Santosh V, Bastia D Proc Natl Acad Sci U S A. 2016; 113(16):E2267-76.
PMID: 27035982 PMC: 4843429. DOI: 10.1073/pnas.1525465113.
Physical activity and cancer prevention : pathways and targets for intervention.
Rogers C, Colbert L, Greiner J, Perkins S, Hursting S Sports Med. 2008; 38(4):271-96.
PMID: 18348589 DOI: 10.2165/00007256-200838040-00002.
Bose M, McConnell K, Gardner-Aukema K, Muller U, Weinreich M, Keck J Mol Cell Biol. 2004; 24(2):774-86.
PMID: 14701749 PMC: 343803. DOI: 10.1128/MCB.24.2.774-786.2004.
Van Slyke C, Grayhack E Nucleic Acids Res. 2003; 31(15):4597-607.
PMID: 12888520 PMC: 169905. DOI: 10.1093/nar/gkg638.
The Sir1 protein's association with a silenced chromosome domain.
Gardner K, Fox C Genes Dev. 2001; 15(2):147-57.
PMID: 11157772 PMC: 312616. DOI: 10.1101/gad.852801.